Valuation: Pacific Biosciences of California, Inc.

Market Cap 417M 361M 341M 310M 580M 39.96B 584M 4.07B 1.57B 20.27B 1.56B 1.53B 64.6B P/E 2026 *
-3.05x
P/E 2027 * -2.89x
Enterprise Value 885M 767M 725M 658M 1.23B 84.92B 1.24B 8.66B 3.34B 43.07B 3.33B 3.25B 137B EV / Sales 2026 *
5.57x
EV / Sales 2027 * 5.11x
Free-Float
91.09%
Yield 2026 *
-
Yield 2027 * -
1 week+7.23%
Current month+1.59%
1 month+17.95%
3 months+2.57%
6 months-1.13%
Current year-20.30%
1 week 1.09
Extreme 1.09
1.22
1 month 0.97
Extreme 0.97
1.38
3 years 0.75
Extreme 0.7537
9.74
Manager TitleAgeSince
Chief Executive Officer 53 05/08/2026
Director of Finance/CFO 57 31/03/2025
Chief Tech/Sci/R&D Officer - 01/07/2012
Director TitleAgeSince
Director/Board Member 67 01/01/2004
Director/Board Member 72 01/01/2009
Director/Board Member 69 18/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%-0.64%+13.87%-87.89% 417M
Average +13.87%-87.89%
Weighted average by Cap. +13.87%-87.89%

Financials

2026 *2027 *
Net sales 159M 138M 130M 118M 221M 15.24B 223M 1.55B 600M 7.73B 597M 584M 24.64B 184M 160M 151M 137M 257M 17.68B 258M 1.8B 696M 8.97B 692M 677M 28.59B
Net income -141M -122M -115M -105M -196M -13.49B -197M -1.37B -531M -6.84B -528M -516M -21.81B -143M -124M -117M -106M -199M -13.73B -201M -1.4B -541M -6.96B -538M -526M -22.19B
Net Debt 469M 406M 384M 349M 653M 44.96B 657M 4.58B 1.77B 22.81B 1.76B 1.72B 72.69B 525M 455M 430M 390M 731M 50.32B 735M 5.13B 1.98B 25.52B 1.97B 1.93B 81.35B
Logo Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.
Employees
-
Date Price Change
16/09/26 EUR 1.180 -0.21%
15/09/26 EUR 1.182 +0.85%
14/09/26 EUR 1.172 +3.72%
11/09/26 EUR 1.130 +3.67%
10/09/26 EUR 1.090 -0.91%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
1.340USD
Average target price
2.157USD
Spread / Average Target
+60.98%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!